$GENE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSCIENT PHARMACEUTICALS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSCIENT PHARMACEUTICALS CORP. Get notifications about new insider transactions in OSCIENT PHARMACEUTICALS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.35 | 26,237 | 35,420 | 203,314 | 229.6 K to 203.3 K (-11.43 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.36 | 9,320 | 12,675 | 229,551 | 238.9 K to 229.6 K (-3.90 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 36,537 | 2,558 | 238,871 | 202.3 K to 238.9 K (+18.06 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Option Exercise | A | 1.70 | 175,000 | 297,500 | 175,000 | |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Grant | A | 0.00 | 70,000 | 0 | 70,000 | 0 to 70 K |
May 22 2006 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Buy | P | 1.29 | 15,000 | 19,350 | 101,529 | 86.5 K to 101.5 K (+17.34 %) |
May 22 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.33 | 30,000 | 39,900 | 125,926 | 155.9 K to 125.9 K (-19.24 %) |
Apr 27 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.71 | 25,000 | 42,750 | 155,926 | 180.9 K to 155.9 K (-13.82 %) |
Apr 27 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.75 | 25,000 | 43,750 | 180,926 | 205.9 K to 180.9 K (-12.14 %) |
Mar 31 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.98 | 10,000 | 19,800 | 205,926 | 215.9 K to 205.9 K (-4.63 %) |
Mar 31 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.98 | 10,000 | 19,800 | 205,926 | 215.9 K to 205.9 K (-4.63 %) |
Mar 22 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.15 | 10,000 | 21,500 | 215,926 | 225.9 K to 215.9 K (-4.43 %) |
Mar 22 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.10 | 10,000 | 21,000 | 225,926 | 235.9 K to 225.9 K (-4.24 %) |
Mar 22 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.08 | 10,000 | 20,800 | 235,926 | 245.9 K to 235.9 K (-4.07 %) |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | A | 1.93 | 100,000 | 193,000 | 100,000 | |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Grant | A | 0.00 | 40,000 | 0 | 86,529 | 46.5 K to 86.5 K (+85.97 %) |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Option Exercise | A | 1.93 | 250,000 | 482,500 | 250,000 | |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Grant | A | 0.00 | 100,000 | 0 | 142,934 | 42.9 K to 142.9 K (+232.92 %) |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Option Exercise | A | 1.93 | 250,000 | 482,500 | 250,000 | |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Grant | A | 0.00 | 100,000 | 0 | 142,934 | 42.9 K to 142.9 K (+232.92 %) |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Option Exercise | A | 1.93 | 200,000 | 386,000 | 200,000 | |
Mar 16 2006 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Grant | A | 0.00 | 80,000 | 0 | 80,000 | 0 to 80 K |
Mar 07 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.10 | 10,000 | 21,000 | 245,926 | 255.9 K to 245.9 K (-3.91 %) |
Mar 01 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.92 | 5,000 | 9,600 | 255,926 | 260.9 K to 255.9 K (-1.92 %) |
Mar 01 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.94 | 5,000 | 9,700 | 260,926 | 265.9 K to 260.9 K (-1.88 %) |
Feb 14 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.10 | 15,000 | 31,500 | 265,926 | 280.9 K to 265.9 K (-5.34 %) |
Feb 09 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.29 | 25,000 | 57,250 | 280,926 | 305.9 K to 280.9 K (-8.17 %) |
Jan 31 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.15 | 10,000 | 21,500 | 305,926 | 315.9 K to 305.9 K (-3.17 %) |
Jan 11 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.60 | 4,277 | 11,120 | 325,926 | 330.2 K to 325.9 K (-1.30 %) |
Jan 11 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.52 | 10,926 | 27,534 | 330,203 | 341.1 K to 330.2 K (-3.20 %) |
Jan 11 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.45 | 15,716 | 38,504 | 341,129 | 356.8 K to 341.1 K (-4.40 %) |
Jan 17 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.50 | 10,000 | 25,000 | 315,926 | 325.9 K to 315.9 K (-3.07 %) |
Jan 09 2006 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.36 | 52,900 | 124,590 | 2,272,935 | 2.3 M to 2.3 M (-2.27 %) |
Jan 04 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.28 | 15,000 | 34,200 | 382,856 | 397.9 K to 382.9 K (-3.77 %) |
Jan 04 2006 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Buy | J | 1.93 | 4,716 | 9,102 | 46,529 | 41.8 K to 46.5 K (+11.28 %) |
Jan 04 2006 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 4,700 | 10,810 | 2,325,835 | 2.3 M to 2.3 M (-0.20 %) |
Jan 04 2006 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 32,300 | 74,290 | 2,330,535 | 2.4 M to 2.3 M (-1.37 %) |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 4,900 | 11,270 | 2,362,835 | 2.4 M to 2.4 M (-0.21 %) |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | A | 2.28 | 6,020 | 13,726 | 6,020 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | D | 1.57 | 5,748 | 9,024 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Option Exercise | D | 1.98 | 272 | 539 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 2.28 | 5,748 | 13,105 | 5,748 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | D | 1.57 | 5,748 | 9,024 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Option Exercise | A | 2.28 | 8,544 | 19,480 | 8,544 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Option Exercise | D | 1.93 | 8,544 | 16,490 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | A | 2.28 | 6,020 | 13,726 | 6,020 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | D | 1.57 | 5,748 | 9,024 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | D | 1.98 | 272 | 539 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | KIRBY PAMELA J | Director | Option Exercise | A | 2.28 | 6,032 | 13,753 | 6,032 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | KIRBY PAMELA J | Director | Option Exercise | D | 1.49 | 6,032 | 8,988 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 2.28 | 10,709 | 24,417 | 10,709 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | D | 1.57 | 10,709 | 16,813 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 2.28 | 7,800 | 17,784 | 7,800 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | D | 1.57 | 7,800 | 12,246 | 0 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | A | 2.28 | 6,128 | 13,972 | 6,128 | |
Dec 29 2005 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Option Exercise | D | 1.93 | 6,128 | 11,827 | 0 | |
Dec 28 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.33 | 79,200 | 184,290 | 2,367,735 | 2.4 M to 2.4 M (-3.24 %) |
Dec 28 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.32 | 130,000 | 301,080 | 2,446,935 | 2.6 M to 2.4 M (-5.04 %) |
Dec 28 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.37 | 455,000 | 1,079,033 | 2,576,935 | 3 M to 2.6 M (-15.01 %) |
Dec 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.38 | 276,300 | 658,174 | 3,031,935 | 3.3 M to 3 M (-8.35 %) |
Dec 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 255,000 | 587,469 | 3,308,235 | 3.6 M to 3.3 M (-7.16 %) |
Dec 20 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.36 | 2,300 | 5,428 | 3,563,235 | 3.6 M to 3.6 M (-0.06 %) |
Dec 20 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 172,000 | 395,600 | 3,565,535 | 3.7 M to 3.6 M (-4.60 %) |
Dec 15 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.32 | 230,300 | 534,135 | 3,737,535 | 4 M to 3.7 M (-5.80 %) |
Dec 15 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 53,240 | 122,452 | 3,967,835 | 4 M to 4 M (-1.32 %) |
Dec 14 2005 | GENE | OSCIENT PHARMACEUT ... | COHEN STEPHEN | SVP and CFO | Buy | P | 2.18 | 1,000 | 2,180 | 2,200 | 1.2 K to 2.2 K (+83.33 %) |
Nov 30 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 7,614 | 533 | 0 | |
Nov 30 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 5,000 | 350 | 7,614 | |
Nov 30 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.00 | 7,614 | 15,228 | 397,856 | 405.5 K to 397.9 K (-1.88 %) |
Nov 30 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 7,614 | 533 | 405,470 | 397.9 K to 405.5 K (+1.91 %) |
Nov 30 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.00 | 5,000 | 10,000 | 392,856 | 397.9 K to 392.9 K (-1.26 %) |
Nov 30 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 5,000 | 350 | 397,856 | 392.9 K to 397.9 K (+1.27 %) |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 5,000 | 350 | 12,614 | |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 15,000 | 1,050 | 17,614 | |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.08 | 3,200 | 6,656 | 392,856 | 396.1 K to 392.9 K (-0.81 %) |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.09 | 1,800 | 3,762 | 396,056 | 397.9 K to 396.1 K (-0.45 %) |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 5,000 | 350 | 397,856 | 392.9 K to 397.9 K (+1.27 %) |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.95 | 5,000 | 9,750 | 392,856 | 397.9 K to 392.9 K (-1.26 %) |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.90 | 10,000 | 19,000 | 397,856 | 407.9 K to 397.9 K (-2.45 %) |
Nov 21 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 15,000 | 1,050 | 407,856 | 392.9 K to 407.9 K (+3.82 %) |
Nov 08 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 250,724 | 17,551 | 633,124 | |
Nov 08 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.73 | 200,724 | 347,253 | 204,633 | 405.4 K to 204.6 K (-49.52 %) |
Nov 08 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.80 | 50,000 | 90,000 | 405,357 | 455.4 K to 405.4 K (-10.98 %) |
Nov 08 2005 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 250,724 | 17,551 | 455,357 | 204.6 K to 455.4 K (+122.52 %) |
Nov 02 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 15,000 | 1,050 | 32,614 | |
Nov 02 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.79 | 15,000 | 26,850 | 392,856 | 407.9 K to 392.9 K (-3.68 %) |
Nov 02 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 15,000 | 1,050 | 407,856 | 392.9 K to 407.9 K (+3.82 %) |
Oct 27 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 15,000 | 1,050 | 47,614 | |
Oct 27 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.95 | 5,000 | 9,750 | 392,856 | 397.9 K to 392.9 K (-1.26 %) |
Oct 27 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.90 | 10,000 | 19,000 | 397,856 | 407.9 K to 397.9 K (-2.45 %) |
Oct 27 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 15,000 | 1,050 | 407,856 | 392.9 K to 407.9 K (+3.82 %) |
Oct 24 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 20,000 | 1,400 | 62,614 | |
Oct 24 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.94 | 10,000 | 19,400 | 392,856 | 402.9 K to 392.9 K (-2.48 %) |
Oct 24 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.90 | 10,000 | 19,000 | 402,856 | 412.9 K to 402.9 K (-2.42 %) |
Oct 24 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 20,000 | 1,400 | 412,856 | 392.9 K to 412.9 K (+5.09 %) |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 5,000 | 350 | 82,614 | |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 10,000 | 700 | 87,614 | |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.20 | 5,000 | 11,000 | 392,856 | 397.9 K to 392.9 K (-1.26 %) |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 5,000 | 350 | 397,856 | 392.9 K to 397.9 K (+1.27 %) |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.14 | 5,000 | 10,700 | 392,856 | 397.9 K to 392.9 K (-1.26 %) |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.10 | 5,000 | 10,500 | 397,856 | 402.9 K to 397.9 K (-1.24 %) |
Oct 03 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 10,000 | 700 | 402,856 | 392.9 K to 402.9 K (+2.55 %) |
Sep 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 15,000 | 1,050 | 97,614 | |
Sep 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.12 | 4,000 | 8,480 | 392,856 | 396.9 K to 392.9 K (-1.01 %) |
Sep 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.18 | 5,000 | 10,900 | 396,856 | 401.9 K to 396.9 K (-1.24 %) |
Sep 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.10 | 6,000 | 12,600 | 401,856 | 407.9 K to 401.9 K (-1.47 %) |
Sep 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 15,000 | 1,050 | 407,856 | 392.9 K to 407.9 K (+3.82 %) |
Sep 20 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.41 | 40,000 | 96,324 | 4,021,075 | 4.1 M to 4 M (-0.98 %) |
Sep 20 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.41 | 105,000 | 252,588 | 4,061,075 | 4.2 M to 4.1 M (-2.52 %) |
Sep 14 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.45 | 23,975 | 58,756 | 4,166,075 | 4.2 M to 4.2 M (-0.57 %) |
Sep 13 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.44 | 50,000 | 121,855 | 4,190,050 | 4.2 M to 4.2 M (-1.18 %) |
Sep 13 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.44 | 205,000 | 500,938 | 4,240,050 | 4.4 M to 4.2 M (-4.61 %) |
Sep 13 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.51 | 100,000 | 250,980 | 4,445,050 | 4.5 M to 4.4 M (-2.20 %) |
Sep 09 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 20,000 | 1,400 | 112,614 | |
Sep 09 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | M | 2.59 | 10,000 | 25,900 | 392,856 | 402.9 K to 392.9 K (-2.48 %) |
Sep 09 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.49 | 10,000 | 24,900 | 402,856 | 412.9 K to 402.9 K (-2.42 %) |
Sep 09 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 20,000 | 1,400 | 412,856 | 392.9 K to 412.9 K (+5.09 %) |
Sep 08 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.58 | 42,000 | 108,486 | 4,545,050 | 4.6 M to 4.5 M (-0.92 %) |
Sep 08 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.47 | 200,000 | 493,560 | 4,587,050 | 4.8 M to 4.6 M (-4.18 %) |
Sep 01 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.35 | 500,000 | 1,175,000 | 4,787,050 | 5.3 M to 4.8 M (-9.46 %) |
Sep 01 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.30 | 1,000,000 | 2,300,000 | 5,287,050 | 6.3 M to 5.3 M (-15.91 %) |
Sep 01 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.28 | 100,000 | 228,000 | 6,287,050 | 6.4 M to 6.3 M (-1.57 %) |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 15,000 | 1,050 | 132,614 | |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 5,000 | 350 | 147,614 | |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.26 | 5,000 | 11,300 | 377,856 | 382.9 K to 377.9 K (-1.31 %) |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.24 | 5,000 | 11,200 | 382,856 | 387.9 K to 382.9 K (-1.29 %) |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.21 | 5,000 | 11,050 | 387,856 | 392.9 K to 387.9 K (-1.27 %) |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 15,000 | 1,050 | 392,856 | 377.9 K to 392.9 K (+3.97 %) |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.15 | 5,000 | 10,750 | 377,856 | 382.9 K to 377.9 K (-1.31 %) |
Aug 31 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 5,000 | 350 | 382,856 | 377.9 K to 382.9 K (+1.32 %) |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 10,000 | 700 | 152,614 | |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 4,500 | 315 | 162,614 | |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | S | 2.09 | 5,000 | 10,450 | 377,856 | 372.9 K to 377.9 K (+1.34 %) |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.05 | 5,000 | 10,250 | 382,856 | 387.9 K to 382.9 K (-1.29 %) |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 10,000 | 700 | 387,856 | 377.9 K to 387.9 K (+2.65 %) |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.15 | 4,500 | 9,675 | 377,856 | 382.4 K to 377.9 K (-1.18 %) |
Aug 29 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 4,500 | 315 | 382,356 | 377.9 K to 382.4 K (+1.19 %) |
Aug 25 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.23 | 200,000 | 446,000 | 6,387,050 | 6.6 M to 6.4 M (-3.04 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.28 | 150,000 | 342,000 | 6,587,050 | 6.7 M to 6.6 M (-2.23 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.29 | 50,000 | 114,680 | 6,737,050 | 6.8 M to 6.7 M (-0.74 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.42 | 100,000 | 242,000 | 6,787,050 | 6.9 M to 6.8 M (-1.45 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.35 | 60,000 | 141,168 | 6,887,050 | 6.9 M to 6.9 M (-0.86 %) |
Aug 22 2005 | GENE | OSCIENT PHARMACEUT ... | EVNIN LUKE | Director | Sell | S | 2.53 | 225,000 | 569,160 | 6,947,050 | 7.2 M to 6.9 M (-3.14 %) |
Aug 17 2005 | GENE | OSCIENT PHARMACEUT ... | BB BIOVENTURES L P | Sell | S | 2.66 | 160,000 | 425,840 | 7,172,050 | 7.3 M to 7.2 M (-2.18 %) | |
Aug 17 2005 | GENE | OSCIENT PHARMACEUT ... | BB BIOVENTURES L P | Sell | S | 2.64 | 150,000 | 396,360 | 7,332,050 | 7.5 M to 7.3 M (-2.00 %) | |
Aug 17 2005 | GENE | OSCIENT PHARMACEUT ... | BB BIOVENTURES L P | Sell | S | 2.61 | 50,000 | 130,350 | 7,482,050 | 7.5 M to 7.5 M (-0.66 %) | |
Aug 17 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 5,500 | 385 | 167,114 | |
Aug 17 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 2.80 | 5,500 | 15,400 | 377,856 | 383.4 K to 377.9 K (-1.43 %) |
Aug 17 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Buy | M | 0.07 | 5,500 | 385 | 383,356 | 377.9 K to 383.4 K (+1.46 %) |
Aug 05 2005 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | M | 0.07 | 10,000 | 700 | 172,614 |